ZYDUS PHARMS FDA Approval ANDA 207812

ANDA 207812

ZYDUS PHARMS

FDA Drug Application

Application #207812

Application Sponsors

ANDA 207812ZYDUS PHARMS

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 2.5MG BASE0METHOTREXATE SODIUMMETHOTREXATE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2017-01-13STANDARD
LABELING; LabelingSUPPL2AP2021-11-08STANDARD
LABELING; LabelingSUPPL4AP2021-11-08STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15
SUPPL4Null7

TE Codes

001PrescriptionAB

CDER Filings

ZYDUS PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207812
            [companyName] => ZYDUS PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHOTREXATE SODIUM","activeIngredients":"METHOTREXATE SODIUM","strength":"EQ 2.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/13\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-01-13
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.